News

Bio-Techne Showcases Breakthrough Solutions at Neuroscience 2024

Bio-Techne Showcases Breakthrough Solutions at Neuroscience 2024

Bio-Techne's Commitment to Neuroscience Research

Bio-Techne Corporation (NASDAQ: TECH) is preparing for an exciting presentation at the Society for Neuroscience's annual meeting, Neuroscience 2024. Scheduled for October 5-9 in Chicago, this prestigious event will feature Bio-Techne as they share advancements that are setting new standards in neuroscience research.

Innovative Solutions on Display

At booth #1165, attendees can check out Bio-Techne's extensive range of life science reagents and analytical instruments. This impressive lineup includes state-of-the-art immunoassays and multiomics solutions, all aimed at simplifying the research process. These tools are designed to boost biomarker discovery, improve neural cell cultures, and innovate drug screening methods.

Highlighting Key Presentations and Technologies

Throughout the event, Bio-Techne will host a nanosymposium on the critical topic of senescence in the aging brain. This session will feature the RNAscope™ Multiomic LS assay, which supports high-throughput spatial analysis for complicated biological systems. Moreover, a poster presentation will emphasize the company's dedication to antibody validation using the hyperplex spatial biology platform from Lunaphore, a move that significantly enhances research accuracy.

Collaboration Spotlight with FUJIFILM Cellular Dynamics

In partnership with FUJIFILM Cellular Dynamics, Bio-Techne will present a Product Theater showcasing intracellular signaling in Alzheimer's disease, with a special emphasis on Simple Western™ automated western technology. This cutting-edge technology enables precise protein size characterization directly from complex samples like tissue or cell lysates, marking an important breakthrough in neurobiological research tools.

Scientific Presentations at the Conference

Bio-Techne's participation in Neuroscience 2024 includes several key presentations, such as:

  • Simple Western™ Capillary Immunoassays: This innovative approach to detailing intracellular signaling in Alzheimer's disease is scheduled for October 7 at 2:30 pm.
  • Investigating Hallmarks of Senescence: A presentation on October 9 will cover a novel RNA-Protein Multiomic Co-Detection Assay.
  • Automated Assay for Precise pTau217 Quantification: Set for October 6, this session will showcase techniques that improve sensitivity in detecting disease markers.
  • Bridging Synaptic Research: Focusing on the interactions between neurexin and neuroligin, this presentation on October 6 will utilize multiomic RNAscope technology for in-depth studies.
  • Spatial Multiomic Assay Analysis: Scheduled for October 8, it will delve into interneuron heterogeneity in the brain.

Additionally, a collaborative presentation will focus on characterizing iPSC-derived human microglial activation, showcasing the integration of advanced technologies in neuroinflammation research.

About Bio-Techne Corporation

Bio-Techne Corporation (NASDAQ: TECH) is a frontrunner in life sciences, offering innovative tools and reagents critical for research and clinical diagnostics. With an extensive portfolio of hundreds of thousands of products, Bio-Techne supports scientific exploration of biological mechanisms and disease progression. Their work propels drug discovery and aids in the development of precise diagnostic tests. In the last fiscal year, Bio-Techne reported around $1.2 billion in net sales and employs about 3,100 professionals worldwide.

Frequently Asked Questions

What will Bio-Techne present at Neuroscience 2024?

Bio-Techne will showcase a range of innovative life science solutions, focusing on tools for neurological research and advancements in biomarker discovery.

Where will the event take place?

The Neuroscience 2024 annual meeting will happen in Chicago from October 5-9, highlighting the latest findings in the field of neuroscience.

What technologies will be highlighted?

Attendees can expect to see demonstrations of high-quality life science reagents, immunoassays, and techniques for spatial biology analysis.

Who will represent Bio-Techne at the conference?

Key figures, including Kim Kelderman, Bio-Techne's President and CEO, along with leading scientists from FUJIFILM and Cell Signaling Technology, will be presenting.

How can I learn more about Bio-Techne's offerings?

To dive deeper into Bio-Techne's innovative products and solutions for neuroscience and more, visit their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Mohegan Sun Arena's $30M Overhaul Elevates Experiences

Updated Category News Views 156

Mohegan Sun Aims for New Heights with Major Overhaul Tuck into this: Mohegan Sun Arena, that entertainment juggernaut nestled in Montville, is gearing up for a massive $30 million facelift. You're talking all-new seating, cutting-edge concessions, and premium hospitality that puts other venues to shame. Over Two Decades of Entertainment Excellence This isn’t just...

Continue Reading
Capitol Securities Adds Financial Veterans to Team

Updated Category News Views 128

Big Moves in Sarasota: Capitol Securities' New Additions In a world where every Wall Street whisper can send ripples through financial markets, Capitol Securities Management's move to bring on Joe Malave and Katy Carrigan is anything but a minor footnote. You'd think, by now, we'd be numb to industry shifts, but when a pro like Malave, with his 30 years of financial...

Continue Reading
Maritime Injury Law: Neidzwski Talks Sea Changes

Updated Category News Views 96

Legal waters are as choppy as the seas themselves, especially in the maritime injury law arena. Nicholas J. Neidzwski, a maritime injury attorney and partner at BoatLaw, LLP, recently waded into these turbulent waters at the 2026 Pacific Admiralty Seminar. This isn’t just any gathering; it’s the West Coast’s legal beacon on all things maritime, drawing in industry...

Continue Reading
Soligenix Holds Steady Amidst Shifting Financial Landscape

Updated Category News Views 53

Stepping into Soligenix's News Every time Soligenix pops up on the radar, it feels like we're watching a biopharma soap opera. This time, they're juggling updates and quarterly numbers that scream both promise and peril. The New Jersey-based company, known for its focus on niche markets with unmet medical needs, tossed out some shiny clinical developments alongside a...

Continue Reading
Beverly Hills Body Academy: A New Era in Contouring

Updated Category News Views 42

Setting New Standards in Body Contouring It's no secret that Beverly Hills is all about luxury and cutting-edge trends. So, when the Beverly Hills Body Academy™ (BHBA) sets up shop in this glitzy locale, it's a pretty loud statement in the world of body contouring. This isn't just another vanity-driven operation; it's about pioneering advancements in the field of body...

Continue Reading
EPG's New Malaysian Factory: A US$120M Commitment

Updated Category News Views 129

In the hustle and bustle of manufacturing, EPG Modular Data Center has hit a landmark moment. They're not just slapping up another building—they're carving out a piece of future tech infrastructure with their fresh Malaysia FIZ Factory. Investing in Regional Strength When you pump US$120 million into a project, you're doing more than sinking cash into concrete—you're...

Continue Reading
Tackling Fake Holiday Webshops: A Security Alert

Updated Category News Views 106

Spotting Bogus Bargains: A Seasonal Security Challenge Here's a festive headache for ya: fake holiday web shops are popping up like those glittery snow globes at a dollar store. Just as holiday shoppers gear up for Black Friday on November 27, there's a troubling fivefold increase in these phony online shops reported over a couple of short months. This isn't just a...

Continue Reading
Lululemon Faces Class Action Amid Sales Decline

Updated Category News Views 136

Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....

Continue Reading
IRTC Faces Investigation: Shares Plunge Amid Uncertainty

Updated Category News Views 48

Securities Trouble on the Horizon: IRTC Takes a Hit Wake up and adjust your seat, folks—iRhythm Technologies (NASDAQ:IRTC) is in the spotlight, and it ain't pretty. Shares nosedived over 30% in a single morning, stirring up quite the murky waters for shareholders. The trigger? A less-than-stellar third-quarter report. The Numbers Don't Lie—Or Do They? Management...

Continue Reading
Buying a Home in East Grand Rapids: Key Tips Revealed

Updated Category News Views 92

Navigating East Grand Rapids Housing Market Jumping into the housing market in East Grand Rapids, Michigan, is like diving headfirst into a spirited game of musical chairs. Blink, and that dream property might have slipped through your fingers. The competition here is fierce, and if you're not coming prepared, you're setting yourself up for a world of disappointment....

Continue Reading

Top 5 Most Recently Viewed Articles

Perpetua Resources Corp. Class Action Lawsuit and Investor Alert

Updated Category News Views 167

Understanding the Class Action Lawsuit Against Perpetua Resources Corp. Investors in Perpetua Resources Corp. (NASDAQ: PPTA) should take note of recent developments regarding a class action securities lawsuit aimed at recovering losses incurred due to alleged securities fraud. This legal action encompasses claims made during a specific period, potentially affecting a...

Continue Reading
Telix Pharmaceuticals Hits Record Revenue and Expands Guidance

Updated Category News Views 390

Telix Pharmaceuticals Reports Record Revenues in Q3 2025 Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) has unveiled an impressive financial performance for the third quarter of 2025, showcasing unaudited group revenues of approximately $206 million. This figure marks a substantial year-over-year increase of 53%, revealing the company's significant growth...

Continue Reading
Bio-Techne Showcases Breakthrough Solutions at Neuroscience 2024

Updated Category News Views 208

Bio-Techne's Commitment to Neuroscience Research Bio-Techne Corporation (NASDAQ: TECH) is preparing for an exciting presentation at the Society for Neuroscience's annual meeting, Neuroscience 2024. Scheduled for October 5-9 in Chicago, this prestigious event will feature Bio-Techne as they share advancements that are setting new standards in neuroscience research....

Continue Reading
Important Update for Lineage, Inc. Investors on Class Action

Updated Category News Views 214

Class Action Suit Opportunities for Lineage, Inc. Investors The Rosen Law Firm, known for advocating investor rights, is calling attention to an essential opportunity for those who purchased common stock of Lineage, Inc. (NASDAQ: LINE). Investors should be aware of the impending lead plaintiff deadline of September 30, 2025. Why Join the Lawsuit? If you bought shares of...

Continue Reading
AST SpaceMobile Prepares for BlueBird 6 Launch and Future Growth

Updated Category News Views 129

AST SpaceMobile Gears Up for BlueBird 6 Launch AST SpaceMobile is set to launch its advanced satellite, BlueBird 6, marking a significant milestone for the company. This launch is crucial for boosting the firm’s space-based cellular broadband network and is being closely watched by investors eager to understand the company’s expansion into full-scale operations. Key...

Continue Reading